
EU Approves Alzheimer’s Drug Kisunla with Strict Conditions
Prime Highlights: The European Union approved Kisunla, an Alzheimer’s drug by Eli Lilly, for treating mild cognitive impairment and early-stage

Prime Highlights: The European Union approved Kisunla, an Alzheimer’s drug by Eli Lilly, for treating mild cognitive impairment and early-stage

Prime Highlights: A new twice-yearly HIV prevention injection, lenacapavir, will be available at low cost in 120 lower-income countries starting

Prime Highlight A study by Karolinska Institutet shows that healthy, full-term infants under three months are also at significant risk

Prime Highlights: A new blood test in the UK could make Alzheimer’s diagnosis faster, easier, and more affordable for patients

Prime Highlights: No link between COVID-19 infection or vaccination during pregnancy and developmental delays in children, according to a large-scale

Prime Highlights: Around 20% of UK medical students are considering dropping out due to poor mental health, according to a

Prime Highlights: Over 12 million people in the UK (one in five adults) are affected by diabetes or prediabetes. 1.3

Prime Highlights: The UK’s National Institute for Health and Care Excellence (NICE) has approved exagamglogene autotemcel (exa-cel), a CRISPR-based gene

Key Highlights: Oesophageal Awareness Month is observed to spread awareness Prolong Sore Throat and Pain Needs Immediate Medical Attention Due

Key Highlights Exercise Improves Brain Insulin Sensitivity Enhanced Glucose Tolerence and Fat Oxidation Neuroprotective benefits of exercise The authors in